Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand · Tablet · Updated Nov 11, 2026

Subvenite 150 mg tablet price what pharmacies pay, and what you should

Pharmacies pay$2.06for 30 tablets · $0.0688 per tablet
Fair cash price$12.87cost + 15% + $10.50 fee
-1.0% in 4 weeks+9.3% in a yearLast change Oct 21, 2026: pharmacies' invoice prices changed (survey)

Is my price fair?

Check the price you were quoted

Type what the pharmacy asked for subvenite 150 mg tablet and see the markup over what they pay.

How many?
$
Pharmacies payNADAC this week$2.06
Online cost-pluscost + 15% + fees$12.37
Fair cash pricecost + 15% + $10.50 fee$12.87
Your quotetype it above-
Pharmacies pay about $2.06 for 30 tablets. A fair cash price is around $12.87. Type your quote to see your markup.

A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.

Subvenite 150 mg price history

What pharmacies pay for 30 tablets, weekly
$1.85$1.97$2.10$2.22DecFebAprJunAugOct
What pharmacies paid for 30 tablets of subvenite 150 mg tablet over 52 weeks: from $1.89 on Nov 12, 2025 to $2.06 on Nov 11, 2026.
Now
$2.06
52-week low
$1.94
52-week high
$2.18
A year ago
$1.89

Why the price changed

EffectiveBeforeAfterChangeReason
Oct 21, 2026$0.0695$0.0688-1.0%pharmacies' invoice prices changed (survey)
Sep 23, 2026$0.0707$0.0695-1.7%pharmacies' invoice prices changed (survey)
Aug 19, 2026$0.0722$0.0707-2.1%pharmacies' invoice prices changed (survey)
Jul 22, 2026$0.0728$0.0722-0.8%pharmacies' invoice prices changed (survey)
Jun 17, 2026$0.0716$0.0728+1.6%pharmacies' invoice prices changed (survey)
May 20, 2026$0.0672$0.0716+6.6%pharmacies' invoice prices changed (survey)
Apr 22, 2026$0.0650$0.0672+3.4%pharmacies' invoice prices changed (survey)
Mar 18, 2026$0.0647$0.0650+0.6%pharmacies' invoice prices changed (survey)

Prices per tablet. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.

What did you pay for subvenite 150 mg tablet? Share it.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Supply status: shortages & recalls

In shortage6 products are short or being discontinued
No ongoing recalls13 recalls on record

Shortages

  • Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 13 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

Every manufacturer and package code

1 company sell subvenite 150 mg tablet under 1 package code (NDC).

MakerPack sizesPackage codesPer unit
OWP Pharmaceuticals, Inc.100 tablets69102-150-06 $0.0688
All 1 package codes

A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.

The generic costs about the same

This brand$2.0630 tablets
Generic lamotrigine$2.06same amount
GenericLamotrigine 150 mg tablet

Questions to ask your pharmacist

  1. "Is the generic right for me?" The generic, lamotrigine 150 mg tablet, costs pharmacies $2.06 for 30 tablets.
  2. "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
  3. "Is a 90-day supply cheaper per tablet?" Dispensing fees are charged per fill, so fewer fills often cost less.
  4. "Would 25 mg tablet work for me instead?" Pharmacies pay $0.0270 per tablet for it, against $0.0688 for this one. Only your prescriber can say whether a different strength or form suits you.
  5. "Do you match other pharmacies or accept discount cards?" Many do, if you ask.

These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.

Other subvenite strengths and forms

Strength and formPer unitPharmacies pay4 weeks52 weeks
10 mg/mL oral suspension Brand$2.86$687.43 / 240 mL+0.1%
Orange (for patients not taking carbamazepine, phenytoin, phenobarbital, primidone, or valproate) pack BrandNot priced this week
25 mg tablet Brand$0.0270$0.81 / 30 tablets+0.8%-11.8%
100 mg tablet Brand$0.0483$1.45 / 30 tablets-0.8%+5.4%
200 mg tablet Brand$0.0801$2.40 / 30 tablets-2.9%+1.8%

Official label & what changed

Last changedOctober 21, 2026
Version4 of 4
EffectiveAug 26, 2026
Read the label

These highlights do not include all the information needed to use SUBVENITE® safely and effectively. See full prescribing information for SUBVENITE®.SUBVENITE (lamotrigine) oral suspensionInitial U.S. Approval: 1994

This drug has a boxed warning

WARNING: SERIOUS SKIN RASHES

SUBVENITE can cause serious rashes requiring hospitalization and discontinuation of treatment. The incidence of these rashes, which have included Stevens-Johnson syndrome, is approximately 0.3% to 0.8% in pediatric patients (aged 2 to 17 years) and 0.08% to 0.3% in adults receiving lamotrigine. One rash-related death was reported in a prospectively followed cohort of 1,983 pediatric patients (aged 2 to 16 years) with epilepsy taking lamotrigine as adjunctive therapy. In worldwide postmarketing experience, rare cases of toxic epidermal necrolysis and/or rash-related death have been reported in adult and pediatric patients, but their numbers are too few to permit a precise estimate of the rate.

In addition to age, factors that may increase the risk of occurrence or the severity of rash caused by lamotrigine include (1) coadministration of lamotrigine with valproate (includes valproic acid and divalproex sodium), (2) exceeding the recommended initial dose of SUBVENITE, (3) exceeding the recommended dose escalation for SUBVENITE, or (4) the presence of the HLA-B*1502 allele. However, cases have occurred in the absence of these factors.

Nearly all cases of life-threatening rashes caused by lamotrigine have occurred within 2 to 8 weeks of treatment initiation. However, isolated cases have occurred after prolonged treatment (e.g., 6 months). Accordingly, duration of therapy cannot be relied upon as means to predict the potential risk heralded by the first appearance of a rash.

Although benign rashes are also caused by lamotrigine, it is not possible to predict reliably which rashes will prove to be serious or life threatening. Accordingly, SUBVENITE should ordinarily be discontinued at the first sign of rash, unless the rash is clearly not drug related. Discontinuation of treatment may not prevent a rash from becoming life threatening or permanently disabling or disfiguring [see Warnings and Precautions (5.1)].

WARNING: SERIOUS SKIN RASHES

See full prescribing information for complete boxed warning.

Cases of life-threatening serious rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis, and/or rash-related death have been caused by lamotrigine, the active ingredient in SUBVENITE. The rate of serious rash is greater in pediatric patients than in adults. Additional factors that may increase the risk of rash include:

coadministration with valproate.

exceeding recommended initial dose of SUBVENITE.

exceeding recommended dose escalation for SUBVENITE.

presence of the HLA-B*1502 allele. (5.1)

Benign rashes are also caused by lamotrigine, the active ingredient in SUBVENITE; however, it is not possible to predict which rashes will prove to be serious or life threatening. SUBVENITE should be discontinued at the first sign of rash, unless the rash is clearly not drug related. (5.1)

Recent major changes (as listed on the label)

Boxed Warning | 08/2026 |

Warnings and Precautions (5.1) | 08/2026 |

Warnings and Precautions (5.4) | 08/2026 |

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Questions about subvenite 150 mg tablet

How much does subvenite 150 mg tablet cost without insurance?

Pharmacies pay about $2.06 for 30 tablets ($0.0688 per tablet) as of November 11, 2026. A fair cash price is about $12.87: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $12.37 including shipping.

Is my price for subvenite 150 mg tablet fair?

Compare it with the fair cash price of $12.87 for 30 tablets. Up to about $16.09 is fair; above $25.74 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.

Is subvenite 150 mg tablet getting more expensive?

Over the last four weeks the price pharmacies pay fell 1.0%. Over a year it rose 9.3%. See the 52-week chart.

Is there a cheaper generic of Subvenite 150 mg tablet?

Yes: lamotrigine 150 mg tablet, which pharmacies get for $2.06 for the same amount.

Who makes subvenite 150 mg tablet?

1 company: OWP Pharmaceuticals, Inc.. See every package code.

Is subvenite in shortage?

Yes - 6 products are listed as short or being discontinued. Details.

Has subvenite been recalled?

13 recalls on record. Recalls name specific lots - check yours.

What does "pharmacies pay" mean?

It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.

Talk about subvenite 150 mg tablet

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.